Antimicrobial Stewardship
Herausgegeben:Pulcini, Céline; Ergonul, Onder; Can, Fusun; Beovic, Bojana
Antimicrobial Stewardship
Herausgegeben:Pulcini, Céline; Ergonul, Onder; Can, Fusun; Beovic, Bojana
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A 'hands on', practical approach, tips to…mehr
Andere Kunden interessierten sich auch für
Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics84,99 €
Ons HaddadChallenges of Geriatric Infections:29,99 €
Advances in Aggregation Induced Emission Materials in Biosensing and Imaging for Biomedical Applications - Part B93,99 €
Ons HaddadThe bacterial world and COVID-1929,99 €
Host-Bacteria Interactions113,99 €
Host-Bacteria Interactions83,99 €
In vitro Environmental Toxicology - Concepts, Application and Assessment189,99 €-
-
-
Antimicrobial Stewardship (AMS), Volume Two includes the experience of ESGAP workshops and courses on antibiotic stewardship since 2012. It combines clinical and laboratory information about AMS, with a focus on human medicine.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A 'hands on', practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
The ESCMID study group on antibiotic policies (ESGAP) is one of the most productive groups in the field, organizing courses and workshops. This book is an ideal tool for the participants of these workshops.
With short chapters (around 1500 words) written on different topics, the authors insisted on the following points: A 'hands on', practical approach, tips to increase success, a description of the most common mistakes, a global picture (out- and inpatient settings, all countries) and a short list of 10-20 landmark references.
Produktdetails
- Produktdetails
- Developments in Emerging and Existing Infectious Diseases Volume 2
- Verlag: Academic Press / Elsevier Science & Technology
- Artikelnr. des Verlages: C2015-0-04271-X
- Seitenzahl: 394
- Englisch
- Abmessung: 18mm x 152mm x 229mm
- Gewicht: 630g
- ISBN-13: 9780128104774
- Artikelnr.: 48166171
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
- Developments in Emerging and Existing Infectious Diseases Volume 2
- Verlag: Academic Press / Elsevier Science & Technology
- Artikelnr. des Verlages: C2015-0-04271-X
- Seitenzahl: 394
- Englisch
- Abmessung: 18mm x 152mm x 229mm
- Gewicht: 630g
- ISBN-13: 9780128104774
- Artikelnr.: 48166171
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Fusun Can, MD Can is an associate professor of medical microbiology at the Koc University School of Medicine. She is specialized in the epidemiology of emerging bacterial pathogens, antibiotic resistance mechanisms and biofilm related infections. She graduated from Hacettepe University School of Medicine in 1989 and completed her residency in 1996 at Ankara University, Department of Microbiology and Clinical Microbiology in Ankara,Turkey. She worked as a research fellow in the Department of Microbiology at the University of Florida School of Medicine, USA. Before joining Koc University, she was the director of the Department of Medical Microbiology at Baskent University, in Ankara. She is responsible for the Microbiology and Biosafety Level III Laboratory at Koc University.
Section A: The Global Picture of Antimicrobial Use and Resistance
1. The Global Crisis of Antimicrobial Resistance
2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance
3. Quality Indicators and Quantity Metrics of Antibiotic Use
Section B: AMS Strategies
4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods
5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing
6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy
8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs
9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship
10. The Role of Pharmacists
11. The Roles of Nurses in Antimicrobial Stewardship
12. Antifungal Stewardship
Section C: AMS in Specific Clinical Settings
13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care
14. Antimicrobial Stewardship: What to Tell the Patients and the General Public
15. Antimicrobial Stewardship in Long-Term Care Facilities
16. Antimicrobial Stewardship in ICU
17. Antimicrobial Stewardship in Hematology Patients
18. AMS in an Era of Multidrug-Resistant Bacteria
Section D: AMS Experiences Around the World
19.1: AMS Initiatives and Policies: The International Picture
19.2: Missions and Objectives of EUCIC and ESGAP
19.3: Antimicrobial Stewardship in Latin America
19.4: Antimicrobial Stewardship in Australia
19.5: Antimicrobial Stewardship in Austria
19.6: Antimicrobial Stewardship in Belgium
19.7: Antimicrobial Stewardship in Bulgaria
19.8: Antimicrobial Stewardship in Croatia
19.9: Antimicrobial Stewardship in England
19.10: Antimicrobial Stewardship in France
19.11: Antimicrobial Stewardship in Germany
19.12: Antimicrobial Stewardship in Greece
19.13: Antimicrobial Stewardship in India
19.14: Antimicrobial Stewardship in Israel
19.15: Antimicrobial Stewardship in Italy
19.16: Antimicrobial Stewardship in Japan
19.17: Antibiotic Stewardship in the Netherlands
19.18: Antimicrobial Stewardship in Scotland
19.19: Antimicrobial Stewardship in Slovenia
19.20: Antimicrobial Stewardship in South Africa
19.21: Antimicrobial Stewardship in Argentina
19.22: Antimicrobial Stewardship in Spain
19.23: Antibiotic Stewardship in Sweden
19.24: Antimicrobial Stewardship in Switzerland
19.25: Antimicrobial Stewardship in Turkey
19.26: Antimicrobial Stewardship in the United States
Section E: Research and Perspectives
20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"
1. The Global Crisis of Antimicrobial Resistance
2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance
3. Quality Indicators and Quantity Metrics of Antibiotic Use
Section B: AMS Strategies
4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods
5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing
6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy
8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs
9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship
10. The Role of Pharmacists
11. The Roles of Nurses in Antimicrobial Stewardship
12. Antifungal Stewardship
Section C: AMS in Specific Clinical Settings
13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care
14. Antimicrobial Stewardship: What to Tell the Patients and the General Public
15. Antimicrobial Stewardship in Long-Term Care Facilities
16. Antimicrobial Stewardship in ICU
17. Antimicrobial Stewardship in Hematology Patients
18. AMS in an Era of Multidrug-Resistant Bacteria
Section D: AMS Experiences Around the World
19.1: AMS Initiatives and Policies: The International Picture
19.2: Missions and Objectives of EUCIC and ESGAP
19.3: Antimicrobial Stewardship in Latin America
19.4: Antimicrobial Stewardship in Australia
19.5: Antimicrobial Stewardship in Austria
19.6: Antimicrobial Stewardship in Belgium
19.7: Antimicrobial Stewardship in Bulgaria
19.8: Antimicrobial Stewardship in Croatia
19.9: Antimicrobial Stewardship in England
19.10: Antimicrobial Stewardship in France
19.11: Antimicrobial Stewardship in Germany
19.12: Antimicrobial Stewardship in Greece
19.13: Antimicrobial Stewardship in India
19.14: Antimicrobial Stewardship in Israel
19.15: Antimicrobial Stewardship in Italy
19.16: Antimicrobial Stewardship in Japan
19.17: Antibiotic Stewardship in the Netherlands
19.18: Antimicrobial Stewardship in Scotland
19.19: Antimicrobial Stewardship in Slovenia
19.20: Antimicrobial Stewardship in South Africa
19.21: Antimicrobial Stewardship in Argentina
19.22: Antimicrobial Stewardship in Spain
19.23: Antibiotic Stewardship in Sweden
19.24: Antimicrobial Stewardship in Switzerland
19.25: Antimicrobial Stewardship in Turkey
19.26: Antimicrobial Stewardship in the United States
Section E: Research and Perspectives
20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"
Section A: The Global Picture of Antimicrobial Use and Resistance
1. The Global Crisis of Antimicrobial Resistance
2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance
3. Quality Indicators and Quantity Metrics of Antibiotic Use
Section B: AMS Strategies
4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods
5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing
6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy
8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs
9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship
10. The Role of Pharmacists
11. The Roles of Nurses in Antimicrobial Stewardship
12. Antifungal Stewardship
Section C: AMS in Specific Clinical Settings
13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care
14. Antimicrobial Stewardship: What to Tell the Patients and the General Public
15. Antimicrobial Stewardship in Long-Term Care Facilities
16. Antimicrobial Stewardship in ICU
17. Antimicrobial Stewardship in Hematology Patients
18. AMS in an Era of Multidrug-Resistant Bacteria
Section D: AMS Experiences Around the World
19.1: AMS Initiatives and Policies: The International Picture
19.2: Missions and Objectives of EUCIC and ESGAP
19.3: Antimicrobial Stewardship in Latin America
19.4: Antimicrobial Stewardship in Australia
19.5: Antimicrobial Stewardship in Austria
19.6: Antimicrobial Stewardship in Belgium
19.7: Antimicrobial Stewardship in Bulgaria
19.8: Antimicrobial Stewardship in Croatia
19.9: Antimicrobial Stewardship in England
19.10: Antimicrobial Stewardship in France
19.11: Antimicrobial Stewardship in Germany
19.12: Antimicrobial Stewardship in Greece
19.13: Antimicrobial Stewardship in India
19.14: Antimicrobial Stewardship in Israel
19.15: Antimicrobial Stewardship in Italy
19.16: Antimicrobial Stewardship in Japan
19.17: Antibiotic Stewardship in the Netherlands
19.18: Antimicrobial Stewardship in Scotland
19.19: Antimicrobial Stewardship in Slovenia
19.20: Antimicrobial Stewardship in South Africa
19.21: Antimicrobial Stewardship in Argentina
19.22: Antimicrobial Stewardship in Spain
19.23: Antibiotic Stewardship in Sweden
19.24: Antimicrobial Stewardship in Switzerland
19.25: Antimicrobial Stewardship in Turkey
19.26: Antimicrobial Stewardship in the United States
Section E: Research and Perspectives
20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"
1. The Global Crisis of Antimicrobial Resistance
2. Antimicrobial Stewardship: Efficacy and Implementation of Strategies to Address Antimicrobial Overuse and Resistance
3. Quality Indicators and Quantity Metrics of Antibiotic Use
Section B: AMS Strategies
4. Improving Antimicrobial Prescribing: Input from Behavioral Strategies and Quality Improvement Methods
5. Education of Healthcare Professionals on Responsible Antimicrobial Prescribing
6. Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
7. Pharmacokinetic and Pharmacodynamic Tools to Increase Efficacy
8. The Use of Computerized Decision Support Systems to Support Antimicrobial Stewardship Programs
9. The Role of Microbiology Laboratory in Promoting Antimicrobial Stewardship
10. The Role of Pharmacists
11. The Roles of Nurses in Antimicrobial Stewardship
12. Antifungal Stewardship
Section C: AMS in Specific Clinical Settings
13. Optimising Prescribing for Acute Respiratory Tract Infections as an Example for Antimicrobial Stewardship in Primary Care
14. Antimicrobial Stewardship: What to Tell the Patients and the General Public
15. Antimicrobial Stewardship in Long-Term Care Facilities
16. Antimicrobial Stewardship in ICU
17. Antimicrobial Stewardship in Hematology Patients
18. AMS in an Era of Multidrug-Resistant Bacteria
Section D: AMS Experiences Around the World
19.1: AMS Initiatives and Policies: The International Picture
19.2: Missions and Objectives of EUCIC and ESGAP
19.3: Antimicrobial Stewardship in Latin America
19.4: Antimicrobial Stewardship in Australia
19.5: Antimicrobial Stewardship in Austria
19.6: Antimicrobial Stewardship in Belgium
19.7: Antimicrobial Stewardship in Bulgaria
19.8: Antimicrobial Stewardship in Croatia
19.9: Antimicrobial Stewardship in England
19.10: Antimicrobial Stewardship in France
19.11: Antimicrobial Stewardship in Germany
19.12: Antimicrobial Stewardship in Greece
19.13: Antimicrobial Stewardship in India
19.14: Antimicrobial Stewardship in Israel
19.15: Antimicrobial Stewardship in Italy
19.16: Antimicrobial Stewardship in Japan
19.17: Antibiotic Stewardship in the Netherlands
19.18: Antimicrobial Stewardship in Scotland
19.19: Antimicrobial Stewardship in Slovenia
19.20: Antimicrobial Stewardship in South Africa
19.21: Antimicrobial Stewardship in Argentina
19.22: Antimicrobial Stewardship in Spain
19.23: Antibiotic Stewardship in Sweden
19.24: Antimicrobial Stewardship in Switzerland
19.25: Antimicrobial Stewardship in Turkey
19.26: Antimicrobial Stewardship in the United States
Section E: Research and Perspectives
20. Methodological Challenges in Evaluating Antimicrobial Stewardship Programs: "Through Measuring to Knowledge"







